← Back
$TEVA All transactions

TEVA PHARMACEUTICAL INDUSTRIES LTD

A

$ Value

$0

Shares

620,110

Price

$0

Filed

Jan 29

Insider

Name

Francis Richard D

Title

President and CEO

CIK

0001673277

Roles

Officer

Transaction Details

Transaction Date

2026-01-27

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

620,110

Footnotes

Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. | Represents restricted shares units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 15, 2026. | The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 3, 2026.

Filing Info

Accession No.

0001193125-26-029300

Form Type

4

Issuer CIK

0000818686

Francis Richard D's History

Date Ticker Type Value
2026-02-15 TEVA M
2026-02-15 TEVA $5.5M
2026-02-15 TEVA M
2026-02-15 TEVA $9.8M
2026-02-15 TEVA M $0
2026-02-15 TEVA M $0
2026-01-27 TEVA A $0
2026-01-27 TEVA A $0
2025-06-05 TEVA A $0

Other Insiders at TEVA (90d)

Insider Bought Sold Last
Francis Richard D
President and CEO
$15.3M 2026-02-15
Sabag Mark
See "Remarks"
2026-01-27
Daniell Richard
Exec. VP, European Commercial
2026-01-27
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
$11.6M 2026-02-26
Hughes Eric A
See "Remarks"
2026-01-27